section name header

Evidence summaries

Drug Treatment for Faecal Incontinence in Adults

Antidiarrhoeal drugs and topical phenylepinephrine may be effective for anal incontinence in chronic diarrhoea, but they also cause adverse effects. Level of evidence: "C"

A Cochrane review 1[Abstract] included 16 studies with a total of 558 patients. Eleven trials were of cross-over design.

Seven trials tested anti-diarrhoeal drugs to reduce faecal incontinence and other bowel symptoms (loperamide, diphenoxylate plus atropine, and codeine). Six trials tested drugs that enhance anal sphincter function (phenylepinephrine gel and sodium valproate). Two trials evaluated osmotic laxatives (lactulose) for the treatment of faecal incontinence associated with constipation in geriatric patients. One trial assessed the use of zinc-aluminium ointment for faecal incontinence.

There was limited evidence that antidiarrhoeal drugs and drugs that enhance anal sphincter tone may reduce faecal incontinence in patients with liquid stools. Loperamide was associated with more adverse effects (such as constipation, abdominal pain, diarrhoea, headache and nausea) than placebo. The drugs acting on the sphincter sometimes resulted in local dermatitis, abdominal pain or nausea. Laxative use in geriatric patients reduced faecal soiling and the need for help from nurses.Zinc-aluminium ointment was associated with improved quality of life, with no reported adverse effects. However, the observed improvement in quality of life was seen in the placebo group as well as the treatment group.

Comment: The quality of evidence is downgraded by imprecise results (small sample sizes and short duration of follow-up).

    References

    • Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2013;(6):CD002116. [PubMed]

Primary/Secondary Keywords